A Novel Network-Based Computational Model for Prediction of Potential LncRNA–Disease Association

Accumulating studies have shown that long non-coding RNAs (lncRNAs) are involved in many biological processes and play important roles in a variety of complex human diseases. Developing effective computational models to identify potential relationships between lncRNAs and diseases can not only help us understand disease mechanisms at the lncRNA molecular level, but also promote the diagnosis, treatment, prognosis, and prevention of human diseases. For this paper, a network-based model called NBLDA was proposed to discover potential lncRNA–disease associations, in which two novel lncRNA–disease weighted networks were constructed. They were first based on known lncRNA–disease associations and topological similarity of the lncRNA–disease association network, and then an lncRNA–lncRNA weighted matrix and a disease–disease weighted matrix were obtained based on a resource allocation strategy of unequal allocation and unbiased consistence. Finally, a label propagation algorithm was applied to predict associated lncRNAs for the investigated diseases. Moreover, in order to estimate the prediction performance of NBLDA, the framework of leave-one-out cross validation (LOOCV) was implemented on NBLDA, and simulation results showed that NBLDA can achieve reliable areas under the ROC curve (AUCs) of 0.8846, 0.8273, and 0.8075 in three known lncRNA–disease association datasets downloaded from the lncRNADisease database, respectively. Furthermore, in case studies of lung cancer, leukemia, and colorectal cancer, simulation results demonstrated that NBLDA can be a powerful tool for identifying potential lncRNA–disease associations as well.

[1]  Maria R. Baer,et al.  FLT3 Inhibitors in Acute Myeloid Leukemia: Current Status and Future Directions , 2017, Molecular Cancer Therapeutics.

[2]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[3]  Lei Wang,et al.  Prediction of microRNA-disease associations based on distance correlation set , 2018, BMC Bioinformatics.

[4]  Hui Liu,et al.  Identification and characterization of long intergenic non-coding RNAs related to mouse liver development , 2014, Molecular Genetics and Genomics.

[5]  Hu Pu,et al.  LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2 , 2015, Oncotarget.

[6]  Lei Wang,et al.  A Novel Probability Model for LncRNA–Disease Association Prediction Based on the Naïve Bayesian Classifier , 2018, Genes.

[7]  Bo Liao,et al.  Global network random walk for predicting potential human lncRNA-disease associations , 2017, Scientific Reports.

[8]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[9]  Howard Y. Chang,et al.  Long noncoding RNAs and human disease. , 2011, Trends in cell biology.

[10]  Xiaoping Cai,et al.  Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia. , 2015, Oncology letters.

[11]  Dan Yang,et al.  The progress and current status of immunotherapy in acute myeloid leukemia , 2017, Annals of Hematology.

[12]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[13]  A. Giuliano,et al.  Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies , 2016, CA: a cancer journal for clinicians.

[14]  Bernhard Kuster,et al.  Lapatinib Resistance in Breast Cancer Cells Is Accompanied by Phosphorylation-Mediated Reprogramming of Glycolysis. , 2017, Cancer research.

[15]  Lin Liu,et al.  Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. , 2014, Molecular bioSystems.

[16]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[17]  Ping He,et al.  Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[18]  Bing-Hong Wang,et al.  Personal recommendation via unequal resource allocation on bipartite networks , 2010 .

[19]  G. Decorti,et al.  Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives. , 2017, Current medicinal chemistry.

[20]  Xing Chen,et al.  Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA , 2015, Scientific Reports.

[21]  Leighton J. Core,et al.  Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.

[22]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[23]  Linlang Guo,et al.  Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2 , 2017, Molecular Cancer.

[24]  C. Yanofsky Establishing the Triplet Nature of the Genetic Code , 2007, Cell.

[25]  Ping Zhang,et al.  Personalized recommendation based on unbiased consistence , 2015 .

[26]  Xian-jun Feng,et al.  Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. , 2014, International journal of clinical and experimental pathology.

[27]  Nicholas T. Ingolia,et al.  Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins , 2013, Cell.

[28]  Feng Zhang,et al.  Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway , 2016, Oncotarget.

[29]  Elisabeth Brambilla,et al.  The 2004 World Health Organization classification of lung tumors. , 2005, Seminars in roentgenology.

[30]  Mary Kay Barton,et al.  Local consolidative therapy may be beneficial in patients with oligometastatic non‐small cell lung cancer , 2017, CA: a cancer journal for clinicians.

[31]  O. Shaker,et al.  Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients , 2017, Scientific Reports.

[32]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[33]  Yixue Li,et al.  Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network , 2017, Scientific Reports.

[34]  Xing Chen KATZLDA: KATZ measure for the lncRNA-disease association prediction , 2015, Scientific Reports.

[35]  Peng Wang,et al.  Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..

[36]  Christopher R. Cabanski,et al.  Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer , 2014, Genome Biology.

[37]  J. Bond Colorectal cancer update. Prevention, screening, treatment, and surveillance for high-risk groups. , 2000, The Medical clinics of North America.

[38]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[39]  Huimin Wang,et al.  Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. , 2015, International journal of clinical and experimental medicine.

[40]  J. Mattick,et al.  Long non-coding RNAs: insights into functions , 2009, Nature Reviews Genetics.

[41]  Donglei Zhou,et al.  Long Noncoding RNA BCYRN1 Promotes the Proliferation of Colorectal Cancer Cells via Up-Regulating NPR3 Expression , 2018, Cellular Physiology and Biochemistry.

[42]  A. Atashi,et al.  Evaluation of MALAT1 gene expression in AML and ALL cell lines , 2015 .

[43]  Zheng Li,et al.  CCAT2: A novel oncogenic long non‐coding RNA in human cancers , 2017, Cell proliferation.

[44]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[45]  C. Ponting,et al.  Evolution and Functions of Long Noncoding RNAs , 2009, Cell.

[46]  C. Garrett,et al.  Current State-of-the-Science Adjuvant and Neoadjuvant Therapy in Surgically Resected Colorectal Cancer , 2014 .

[47]  Wei Zhang,et al.  LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia. , 2017, Molecular medicine reports.

[48]  Thomas D. Wu,et al.  Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events , 2012, Genome research.